Skip to content

Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors

Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02482922
Acronym
IETnutrition
Enrollment
15
Registered
2015-06-26
Start date
2015-05-31
Completion date
2017-01-31
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Pre-Diabetic

Keywords

feasibility studies, intervention, Pre-Hypertensive, Pre-Hyperlipidemia

Brief summary

Purpose : Test the feasibility (acceptability, adherence) of a home-based interval exercise training (IET) and nutrition program, as well as its preliminary effects on resting heart rate, blood pressure, fasting glucose, HDL, cholesterol, weight and percent body fat, among primary care patients who have at least one risk factor for cardiovascular disease (CVD). Participants : 30 patients who receive care from the University of North Carolina (UNC) Family Medicine Center (FMC) and meet the inclusion criteria defined below (i.e. general FMC patients, not diagnosed with severe illness), will be enrolled to test the feasibility of the home-based interval exercise and nutrition program. Procedures (methods): A home-based IET and nutrition program will be piloted in 2 phases. In Phase I, 15 patients will be enrolled into the program, which will take approximately 3 months. At baseline, data will be collected on age, height, weight, resting heart rate, blood pressure, fasting glucose, hemoglobin A1c, fasting lipids, cholesterol, insulin, percent body fat, cardiovascular fitness, and use a series of questionnaires to evaluate mood, sleep, hunger, and quality of life. At closeout, the investigators will measure patients' adherence to each component of the intervention. In Phase II, an additional 15 new patients will be enrolled in either the identical protocol, or a slightly modified intervention (if necessary based upon our results from Phase I). All patients will have the same variables measured at baseline during their study visit at 3, 6 and 12 months after enrollment into the study.

Interventions

OTHERExercise & Dietary Supplement

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Patients are: 1. \> 18-85 years; 2. receive primary care in the FMC (\> 1 visit during the previous year); and 3. have ≥1 risk factor or developing risk factors for CVD (blood pressure \>130/85 mmHG, BMI \>25 kg/m2(or \ 20 lbs overweight), Fasting glucose \>110 mg/dl, OR 4) HDL \<30) (all identified via medical record)

Exclusion criteria

1. those for whom exercise and/or diet are contraindicated (e.g., scheduled for arthroplasty) or who are at risk of death in the next year (e.g., Class IV heart failure, end-stage renal disease). 2. those taking medication for diabetes, blood pressure, and lipids for more than 2 years. 3. pregnant or planning on becoming pregnant within the next year. 4. Allergic to any ingredient in the nutritional meal replacement.

Design outcomes

Primary

MeasureTime frame
Number of participants that complete exercise program3 months
Number of participants that complete nutrition program3 months
Number of exercise sessions completed3 months
Number of days nutrition program followed3 months

Secondary

MeasureTime frame
Change in Cardiorespiratory Fitness at 3 months, 6 months, and 12 months3 months, 6 months, 12 months
Change in hemoglobin A1c at 3 months, 6 months, 12 months3 months, 6 months, 12 months
Change in fat mass at 3 months, 6 months, and 12 months3 months, 6 months, 12 months
Change in lean mass at 3 months, 6 months, and 12 months3 months, 6 months, 12 months
Change in blood lipids at 3 months, 6 months, 12 months3 months, 6 months, 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026